Edarbi
Edarbi

1.52
Used to address blood pressure and heart conditions, this generic medicine blocks specific receptors to decrease systemic vascular resistance.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Azilsartan medoxomil
Reference Brand
Azilsartan medoxomil
Product Origin
Generic Alternative
Reference Manufacturer
Takeda
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antihypertensives
Product Category
Angiotensin II Receptor Antagonist
Pharmacological Class
ARB
Clinical Indications
Manufacturer Description
Utilized to manage elevated systemic blood pressure to alleviate cardiac strain and support vascular endothelial safety.
Mechanism of Action
Selectively blocks the binding of vasoconstricting angiotensin II to AT1 receptors in cardiac and vascular tissues.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
24 hours
Contraindications
Pregnancy, Concurrent use of aliskiren in diabetic patients
Severe Adverse Events
Angioedema — requires immediate medical attention, Severe acute renal impairment — requires immediate medical attention
Common Side Effects
Dizziness, Headache, Cough
Uncommon Side Effects
Fatigue, Hypotension, Hyperkalemia
Drug Interactions
Lithium, Potassium Supplements, NSAIDs
Pregnancy Safety Warnings
TGA Category D: High risk of fetal toxicity and death. Contraindicated in pregnancy. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Edarbi is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Antidepressant Tablets - Avanza Price